Indaptus Therapeutics Stock Technical Analysis
| INDP Stock | USD 1.65 0.13 7.30% |
As of the 13th of February 2026, Indaptus Therapeutics retains the Standard Deviation of 8.67, market risk adjusted performance of (0.07), and Risk Adjusted Performance of (0.02). Indaptus Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Indaptus Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Indaptus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IndaptusIndaptus Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Indaptus Therapeutics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 10.0 | Buy | 1 | Odds |
Most Indaptus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Indaptus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Indaptus Therapeutics, talking to its executives and customers, or listening to Indaptus conference calls.
Can Biotechnology industry sustain growth momentum? Does Indaptus have expansion opportunities? Factors like these will boost the valuation of Indaptus Therapeutics. Market participants price Indaptus higher when confident in its future expansion prospects. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Indaptus Therapeutics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding Indaptus Therapeutics requires distinguishing between market price and book value, where the latter reflects Indaptus's accounting equity. The concept of intrinsic value - what Indaptus Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Indaptus Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Indaptus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Indaptus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Indaptus Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Indaptus Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Indaptus Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Indaptus Therapeutics.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Indaptus Therapeutics on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Indaptus Therapeutics or generate 0.0% return on investment in Indaptus Therapeutics over 90 days. Indaptus Therapeutics is related to or competes with Biomotion Sciences, Revelation Biosciences, Psyence Biomedical, GT Biopharma, Avenue Therapeutics, Protagenic Therapeutics, and Lipella Pharmaceuticals. Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunothe... More
Indaptus Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Indaptus Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Indaptus Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 51.64 | |||
| Value At Risk | (13.41) | |||
| Potential Upside | 16.13 |
Indaptus Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Indaptus Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Indaptus Therapeutics' standard deviation. In reality, there are many statistical measures that can use Indaptus Therapeutics historical prices to predict the future Indaptus Therapeutics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (1.06) | |||
| Treynor Ratio | (0.08) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Indaptus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Indaptus Therapeutics February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 6.11 | |||
| Coefficient Of Variation | (2,894) | |||
| Standard Deviation | 8.67 | |||
| Variance | 75.17 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (1.06) | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 51.64 | |||
| Value At Risk | (13.41) | |||
| Potential Upside | 16.13 | |||
| Skewness | 1.26 | |||
| Kurtosis | 3.89 |
Indaptus Therapeutics Backtested Returns
Indaptus Therapeutics holds Efficiency (Sharpe) Ratio of -0.0208, which attests that the entity had a -0.0208 % return per unit of risk over the last 3 months. Indaptus Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Indaptus Therapeutics' Risk Adjusted Performance of (0.02), standard deviation of 8.67, and Market Risk Adjusted Performance of (0.07) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 3.92, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Indaptus Therapeutics will likely underperform. At this point, Indaptus Therapeutics has a negative expected return of -0.18%. Please make sure to check out Indaptus Therapeutics' total risk alpha, as well as the relationship between the kurtosis and day typical price , to decide if Indaptus Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.21 |
Weak reverse predictability
Indaptus Therapeutics has weak reverse predictability. Overlapping area represents the amount of predictability between Indaptus Therapeutics time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Indaptus Therapeutics price movement. The serial correlation of -0.21 indicates that over 21.0% of current Indaptus Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.21 | |
| Spearman Rank Test | -0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 0.26 |
Indaptus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Indaptus Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Indaptus Therapeutics across different markets.
About Indaptus Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Indaptus Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Indaptus Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Indaptus Therapeutics price pattern first instead of the macroeconomic environment surrounding Indaptus Therapeutics. By analyzing Indaptus Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Indaptus Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Indaptus Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Payables Turnover | 0.28 | 0.27 | Days Of Inventory On Hand | 49.93 | 44.38 |
Indaptus Therapeutics February 13, 2026 Technical Indicators
Most technical analysis of Indaptus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Indaptus from various momentum indicators to cycle indicators. When you analyze Indaptus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 6.11 | |||
| Coefficient Of Variation | (2,894) | |||
| Standard Deviation | 8.67 | |||
| Variance | 75.17 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.59) | |||
| Total Risk Alpha | (1.06) | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 51.64 | |||
| Value At Risk | (13.41) | |||
| Potential Upside | 16.13 | |||
| Skewness | 1.26 | |||
| Kurtosis | 3.89 |
Indaptus Therapeutics February 13, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Indaptus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 6,328 | ||
| Daily Balance Of Power | (0.76) | ||
| Rate Of Daily Change | 0.93 | ||
| Day Median Price | 1.71 | ||
| Day Typical Price | 1.69 | ||
| Price Action Indicator | (0.12) |
Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.